Pseudoxanthoma elasticum is a metabolic disease

Journal of Investigative Dermatology

Volumn 129, Issue 2, 2009, Pages 348-354

  Jiang, Qiujie ^a   Endo, Masayuki ^b   Dibra, Florian ^a   Wang, Krystle ^a   Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; HISTOPATHOLOGY; METABOLIC DISORDER; MINERALIZATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOXANTHOMA ELASTICUM; SKIN GRAFT; VIBRISSA;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CAPILLARIES; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MINERALS; PSEUDOXANTHOMA ELASTICUM; SKIN; SKIN TRANSPLANTATION; VIBRISSAE;

EID: 58449106109     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.212     Document Type: Article

References (26)

1. Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD (2002) Characterization of the drug resistance and transport properties of multi-drug resistance protein 6 (MRP6, ABCC6). Cancer Res 62: 6172-7
2. Belinsky MG, Kruh GD (1999) MOAT-E (ARA) is a full length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br J Cancer 80:1342-9
3. Capla JM, Ceradini DJ, Tepper OM, Callaghan MJ, Bhatt KA, Galiano RD et al. (2006) Skin graft vascularization involves precisely regulated regression and replacement of endothelial cells through both angiogenesis and vasculogenesis. Plast Reconstr Surg 117:836-44
4. Carson FL (1997) Histotechnology: A Self-Instructional Text. American Society of Clinical Pathology, Chicago, p. 222
5. Gheduzzi D, Boraldi F, Annovi G, DeVincenzi CP, Schurgers LJ, Vermeer C et al. (2007) Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab Invest 87:998-1008
6. Hendig D, Arndt M, Szliska C, Kleesiek K, Götting C (2007) SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum. Clin Chem 53:829-36
7. Hendig D, Zarbock R, Szliska C, Kleesiek K, Götting C (2008) The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin Biochem 41:407-12
8. Iliás A, Urban Z, Seidl TL, Le Saux O, Sinkó E, Boyd CD et al. (2002) Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 277:16860-7
9. Jiang Q, Li Q, Uitto J (2007) Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors. J Invest Dermatol 127:1392-4102
10. Klement JF, Matsuzaki Y, Jiang Q-J, Terlizzi J, Choi HY, Fujimoto N et al. (2005) Targeted ablation of the ABCC6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 25:8299-310
11. LaRusso J, Jiang Q, Li Q, Uitto J (2007) Ectopic mineralization of connective tissue in Abcc6(-/-) mice: effects of dietary modifications and a phosphate binder - a preliminary study. Exp Dermatol 17:203-207
12. LeSaux O, Bunda S, Van Wart CM, Douet V, Got L, Martin L et al. (2006) Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J Invest Dermatol 126:1497-505
13. Li Q, Jiang Q, Pfendner E, Váradi A, Uitto J (2008a) Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms. Exp Dermatol (in press).
14. -/-). J Invest Dermatol 128:1160-4
15. Matsuo S, Kurisaki A, Sugino H, Hashimoto I, Nakanishi H (2007) Analysis of skin graft survival using green fluorescent protein transgenic mice. J Med Invest 54:267-75
16. Matsuzaki Y, Nakano A, Jiang QJ, Pulkkinen L, Uitto J (2005) Tissue-specific expression of the ABCC6 gene. J Invest Dermatol 125:900-5
17. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-77
18. Neldner KH, Struk B (2002) Pseudoxanthoma elasticum In: Connective Tissue and its Heritable Disorders: Molecular, Genetic and Medical Aspects. Royce PM, Steinmann B (eds), Wiley-Liss Inc.: NY, 561-83
19. Pfendner E, Uitto J, Gerard GF, Terry SF (2008) Pseudoxanthoma elasticum: genetic diagnostic markers. Expert Opin Med Diagn 2:1-17
20. Pfendner EG, Vanakker OM, Terry SF, Vourthis S, McAndrew PE, McClain MR et al. (2007) Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum. J Med Genet 44: 621-8
21. Quaglino D, Boraldi F, Barbieri D, Croce A, Tiozzo R, Pasquali-Ronchetti I (2000) Abnormal phenotype of in vitro dermal fibroblasts from patients with pseudoxanthoma elasticum (PXE). Biochim Biophys Acta 1501:51-62
22. Quaglino D, Sartor L, Garbisa S, Boraldi F, Croce A, Passi A et al. (2005) Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential. Biochim Biophys Acta 1741:42-7
23. Ringpfeil F, Pulkkinen L, Uitto J (2001) Molecular genetics of pseudoxanthoma elasticum. Exp Dermatol 10:221-8
24. Scheffer GL, Hu X, Pijnenborg AC, Wijnholds J, Bergen AA, Scheper RJ (2002) MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest 82:515-8
25. Uitto J, Pulkkinen L, Ringpfeil F (2001) Molecular genetics of pseudoxanthoma elasticum: a metabolic disorder at the environment-genome interface? Trends Mol Med 7:13-7
26. Zarbock R, Hendig D, Szliska C, Kleesiek K, Götting C (2007) Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin Chem 53:1734-40